Journal of Cancer Therapy
Vol.9 No.11(2018), Paper ID 88518, 16
pages
DOI:10.4236/jct.2018.911073
Efficacy of Nilotinib versus Imatinib in Philadelphia Positive Patients with Chronic Myeloid Leukemia in Early Chronic Phase Who Have a Warning Molecular Response to Imatinib
Amen Hamdy Zaky Aly, Ahmed EL Sayed Mohammed Khalifa, Esraa Abdallah Abdelkariem Gadallah
Department of Medical Oncology, South Egypt Cancer Institute, Assuit University, Assiut, Egypt
Department of Clinical Oncology, Faculty of Medicine, Sohag University, Sohag, Egypt
Department of Medical Oncology, Sohag Cancer Center, Sohag, Egypt
Copyright © 2018 Amen Hamdy Zaky Aly, Ahmed EL Sayed Mohammed Khalifa, Esraa Abdallah Abdelkariem Gadallah et al. This is
an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any
medium, provided the original work is properly cited.
How to Cite this Article
Aly, A. , Khalifa, A. and Gadallah, E. (2018) Efficacy of Nilotinib versus Imatinib in Philadelphia Positive Patients with Chronic Myeloid Leukemia in Early Chronic Phase Who Have a Warning Molecular Response to Imatinib.
Journal of Cancer Therapy,
9, 883-897. doi:
10.4236/jct.2018.911073.